Patents by Inventor Peter T. G. Sillekens

Peter T. G. Sillekens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8106172
    Abstract: The present invention is related to nucleic acid sequences that can be used in the field of virus diagnostics, more specifically the diagnosis of infections with a novel human coronavirus causing Severe Acute Respiratory Syndrome (SARS). With the present invention nucleotide sequences are provided that can be used as primers and probes in the amplification and detection of SARS nucleic acid. The oligonucleotide sequences provided with the present invention are located in the replicase gene, the nucleocapsid gene and the 3? end non-coding region of the SARS Coronavirus genome. It has been found that, by using the sequences of the present invention in methods for the amplification and detection of nucleic acid a sensitive and specific detection of SARS Coronavirus can be obtained. The oligonucleotide sequences according to the present invention are especially useful in methods for the amplification of nucleic acid.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: January 31, 2012
    Assignee: Biomerieux, B.V.
    Inventors: Peter T. G. Sillekens, Marlieke Overdijk, Saskia van de Laar
  • Patent number: 5616685
    Abstract: The present invention relates to a protein antigen which is reactive towards an auto-antibody which is associated with an auto-immune disease, and the use of this protein in diagnostic tests relating to auto-immune diseases.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: April 1, 1997
    Assignee: Akzo Nobel N.V.
    Inventors: Walter J. Van Venrooij, Peter T. G. Sillekens, Winand J. A. Habets